Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | CNR1 | P21554 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | BRS3 | P32247 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25370642 | 0.89 | TRPV4 (0.36) | KDM4ETRPV4BRS3 | |
| SCHEMBL25370638 | 0.89 | TRPV4 (0.36) | KDM4ETRPV4BRS3 | |
| SCHEMBL25370635 | 0.89 | TRPV4 (0.36) | KDM4ETRPV4BRS3 | |
| SCHEMBL26065760 | 0.84 | CNR1 (0.37) | KDM4ETRPV4LMNAGAAALDH1A1 | |
| SCHEMBL26065761 | 0.82 | TRPV4 (0.38) | KDM4ETRPV4LMNAGAAALDH1A1 | |
| SCHEMBL26065962 | 0.81 | EPHX2 (0.38) | KDM4ETRPV4LMNAGAAALDH1A1 | |
| SCHEMBL26065772 | 0.80 | TRPV4 (0.40) | KDM4ETRPV4GAAALDH1A1POLB | |
| SCHEMBL26065214 | 0.77 | KDM4E (0.41) | KDM4ETRPV4ALDH1A1KMT2ACNR1 | |
| SCHEMBL26065776 | 0.76 | TRPV4 (0.38) | KDM4ETRPV4LMNAGAAALDH1A1 | |
| SCHEMBL26065890 | 0.75 | KCNH2 (0.41) | KDM4ETRPV4LMNAGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164063-A1 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | BIOGEN MA INC. (US) | 2023-08-31 | — | — | WO | disclosed |